Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00381316 · ClinicalTrials.gov registry record · Phase 4
Comparison of Diagnostic Rest/Stress SPECT Results for Patients With Myocardial Ischemia and Infarction Using Myoview in Both Single and Dual Isotope Acquisition Approaches
A Phase 4 study, sponsored by GE Healthcare.
- Completed
- Registry status
- Phase 4
- Development phase
- 291
- Enrollment target
NCT00381316 is a Phase 4 study that has completed, run by GE Healthcare. The registered enrollment target is 291 participants.
The verdict
NCT00381316, a Phase 4 study, has completed, sponsored by GE Healthcare.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 291 participants
- Enrollment target
Study Summary
The study is designed to determine whether a dual isotope protocol is equivalent to a single isotope in the diagnosis of myocardial ischemia and infarction using MYOVIEW SPECT imaging.
Interventions
- DRUG Technetium Tc99m Tetrofosmin injections
- DRUG Thallous Chloride T1-201
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 291 participants |
| Start Date | 2006-07 |
| Est. Completion | 2006-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00381316
The ClinicalTrials.gov registry entry for NCT00381316 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 291 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GE Healthcare, which has 99 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Technetium Tc99m Tetrofosmin injections is the first listed.
NCT00381316 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00381316 about?
NCT00381316 is a clinical study titled "Comparison of Diagnostic Rest/Stress SPECT Results for Patients With Myocardial Ischemia and Infarction Using Myoview in Both Single and Dual Isotope Acquisition Approaches". The study is designed to determine whether a dual isotope protocol is equivalent to a single isotope in the diagnosis of myocardial ischemia and infarction using MYOVIEW SPECT imaging.
What is the current status of trial NCT00381316?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 291 participants. The study started on 2006-07. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00381316?
The interventions under investigation include: Technetium Tc99m Tetrofosmin injections (DRUG), Thallous Chloride T1-201 (DRUG).
Who is sponsoring clinical trial NCT00381316?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.